Frederick R.
Appelbaum
M.D.
206-667-4412
Fred Hutchinson Cancer Center
1100 Fairview Ave N, D5-310
Seattle, WA 98109
Photo: Robert Hood / Fred Hutch News Service
Education, Training, Board Certifications
- M.D., Tufts University
- Residency, University of Michigan Medical Center
- Clinical Associate, National Cancer Institute
- Medical Oncology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Clinical Expertise
- Hematopoietic stem cell transplantation
- Hematologic malignancies
- Leukemia
- Lymphoma
Affiliations
- Fred Hutchinson Cancer Center - Faculty & Lab
- University of Washington
- Fred Hutchinson Cancer Center - Provider
Publications
Research and/or clinical interests
Dr. Fred Appelbaum studies the biology and treatment of leukemias, lymphomas and other blood cancers and sees patients with these disorders. He has made numerous landmark contributions to his field. Notably, he helped develop Fred Hutch’s renowned program in blood stem cell transplantation. He also participated in Fred Hutch’s pioneering work to develop targeted antibody-based cancer therapies. Today, Dr. Appelbaum leads Fred Hutch’s Adult Leukemia Research Center and the Hematologic Malignancy Program of the Fred Hutch/University of Washington Cancer Consortium. These efforts are aimed at enhancing our understanding of these diseases and improving treatments like blood stem cell transplantation. As Fred Hutch deputy director, Dr. Appelbaum leads the implementation of key scientific strategies and partnerships. He also helps to ensure that Fred Hutch advances are shared with the wider community.